Eggs may help curb hunger, preserve muscle, and fill nutrient gaps after stopping GLP-1 weight-loss injections, offering a simple food-based support strategy.
Eggs may help reduce hunger and support weight maintenance after stopping GLP-1 weight-loss injections by naturally boosting satiety hormones, preserving muscle, and filling key nutrient gaps (1✔ ✔Trusted Source
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
Go to source
).
For many people, weight-loss injections such as Wegovy and Mounjaro have felt like a long-awaited breakthrough, making it easier to eat less. In just a few years, these GLP-1 medications have transformed obesity treatment and reshaped how people view appetite and willpower. Their popularity, however, brings an uncomfortable question that more users now face: what happens after you stop?
People discontinue GLP-1 drugs for several reasons, including cost, side effects, or because they have reached a weight they are satisfied with. A growing number are searching for ways to taper off these injections or replicate some of their effects through diet. One unexpectedly simple option to consider, whether still using these drugs, gradually reducing them, or stopping entirely, is the everyday egg (2✔ ✔Trusted Source
Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity The SURMOUNT-4 Randomized Clinical Trial
Go to source).
TOP INSIGHT
Did You Know?
Eating eggs can naturally boost the body’s own GLP-1 hormone, helping people feel fuller longer and eat less, an effect similar to weight-loss injections.
#glp1drugs #eggs #medindia
Weight Regain and Hormonal Rebound
The core challenge with nearly every weight-loss approach is regaining weight. After weight drops, the body resists, increasing hunger and altering metabolism in ways that favor weight returning, driven by powerful physiological and metabolic forces. Long-term data on GLP-1 medications show that once people stop taking them, they regain more than half of the weight they initially lost.
This rebound can be even stronger than with other dieting methods because of how GLP-1 drugs interact with appetite hormones. Evidence indicates that the body’s natural release of the satiety hormone GLP-1 after meals may decrease, either because it is broken down more quickly or because the body becomes less responsive. As a result, hunger returns sooner, making long-term weight maintenance feel like a steep uphill battle.
Eggs as Natural Appetite Regulators
This is where eggs can make a difference. They are naturally rich in nutrients, supplying high-quality protein that contains all essential amino acids, along with vitamin D and a wide range of micronutrients. Eggs are also among the most sustainable animal proteins and are highly affordable (3✔ ✔Trusted Source
Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial
Go to source
).
Past fears about eggs and health have steadily faded as clearer evidence has emerged. Earlier alarm around egg consumption has largely diminished. In the United Kingdom, egg intake is climbing, with about 37 million eggs eaten daily, or roughly three to four per person each week.
A key reason eggs matter is their effect on appetite. Repeated findings show that eating eggs helps people feel fuller for longer and consume less at later meals, including those who are overweight or obese. This happens partly because egg protein stimulates the body’s own release of GLP-1 while suppressing the hunger hormone ghrelin.
Food-Based Support After Injections
In this way, eggs act like a natural GLP-1 agonist rather than a medication. The effect becomes stronger when eggs are paired with fiber-rich foods such as wholegrain toast, which further enhances GLP-1 release and delivers added health benefits. This combination makes eggs a practical substitute for some appetite-controlling effects of injections, especially for those lowering their dose or stopping completely (4✔ ✔Trusted Source
Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
Go to source
).Eggs are also valuable for people who continue using GLP-1 drugs. Weight loss does not involve fat alone; muscle is often lost as well, particularly with these medications. Preserving muscle depends on adequate protein intake, yet this can be challenging when appetite is suppressed and food intake is low.
Protein, Muscle, and Nutrient Gaps
Evidence suggests that consuming around 1 gram of protein per kilogram of body weight or more is linked to better muscle preservation. Eggs provide a convenient, portion-controlled way to meet these targets when large meals are unappealing.
Beyond protein, eggs deliver nutrients many people fail to consume in sufficient amounts. In the United Kingdom, vitamin D intake is commonly low, especially in winter. A 2025 analysis found that individuals taking GLP-1 drugs were lacking several essential nutrients, including calcium, iron, magnesium, potassium, and vitamins A, C, D, E, and K.
Everyday Food With Lasting Impact
This is significant because people living with obesity may already be deficient in nutrients such as vitamin E, selenium, and zinc. Eggs offer a cost-effective way to address these shortfalls, particularly for those using GLP-1 medications.
Now may be the right time to rediscover the value of an everyday food. Eggs are not nature’s Wegovy or Mounjaro, and presenting them that way would be misleading. Yet their influence on appetite, protein intake, and overall nutrition deserves attention.
Whether someone is considering GLP-1 drugs, currently using them, or planning an exit strategy, eggs could become a quiet ally. As more people move away from these powerful medications, simple foods like eggs may play an important role in what follows.
References:
- Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension – ( https://pubmed.ncbi.nlm.nih.gov/35441470/ )
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity The SURMOUNT-4 Randomized Clinical Trial – ( https://jamanetwork.com/journals/jama/fullarticle/2812936)
- Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial – ( https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.14242)
- Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study – (https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1566498/full )
Source-Medindia